These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 231533)

  • 21. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD; Shahid M
    Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G; Prigent AF; Picq M; Pacheco H
    Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ; England PJ
    Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
    Curtis-Prior PB; Chan YH
    Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
    [No Abstract]   [Full Text] [Related]  

  • 27. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
    Hunt NH; Evans T
    Biochim Biophys Acta; 1980 Jun; 613(2):499-506. PubMed ID: 6256001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 29. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
    Worby A; Mensah LM; Murray KJ
    Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
    Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
    Frossard N; Landry Y; Pauli G; Ruckstuhl M
    Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-(4-Aminophenyl)isoquinoline derivatives. Potent inhibitors of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex.
    Davis CW; Walker KA
    Biochem Pharmacol; 1984 Apr; 33(8):1205-12. PubMed ID: 6324818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
    J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.
    Shin HJ; Kim HJ; Kwak JH; Chun HO; Kim JH; Park H; Kim DH; Lee YS
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2313-6. PubMed ID: 12161123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
    Killackey JJ; Killackey BA; Philp RB
    Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.